EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey.

doi:10.1097/JTO.0000000000000422

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Mar 2015

Yatabe Yasushi, Kerr Keith M, Utomo Ahmad, Rajadurai Pathmanathan, Tran Van Khanh, Du Xiang, Chou Teh-Ying, Enriquez Ma Luisa D, Lee Geon Kook, Iqbal Jabed, Shuangshoti Shanop, Chung Jin-Haeng, Hagiwara Koichi, Liang Zhiyong, Normanno Nicola, Park Keunchil, Toyooka Shinichi, Tsai Chun-Ming, Waring Paul, Zhang Li, McCormack Rose, Ratcliffe Marianne, Itoh Yohji, Sugeno Masatoshi, Mok Tony

Abstract excerpt

INTRODUCTION: The efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer (NSCLC) patients necessitates accurate, timely testing. Although EGFR mutation testing has been adopted by many laboratories in Asia, data are lacking on the proportion of NSCLC patients tested in each country, and the most commonly used testing methods. METHODS: A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Asia

Share to Carcinoma, Squamous Cell

Share to Databases, Factual

Share to DNA, Neoplasm

Share to Neoplasm Staging

Share to Pacific Islands

Share to Reagent Kits, Diagnostic

Source

Open in PubMed Open full text

Identifiers

PMID: 25376513
DOI: 10.1097/JTO.0000000000000422
PMCID: PMC4342317

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey.PMID 25376513Read ↗

EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital.Semantic proximity Read ↗

Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: a combined clinical-molecular pathological approach.Semantic proximity Read ↗

NSCLC molecular testing in Central and Eastern European countries.Semantic proximity Read ↗

Optimizing management of stage IV EGFR mutant non‐small cell lung cancer in Asia: An expert opinionSemantic proximity Read ↗

Worldwide Frequency of Commonly Detected EGFR Mutations.Semantic proximity Read ↗

EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study.Semantic proximity Read ↗

Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries.Semantic proximity Read ↗

A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).Semantic proximity Read ↗

Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia.Semantic proximity Read ↗

Utilisation and Determinants of Epidermal Growth Factor Receptor Mutation Testing in Patients with Non-small Cell Lung Cancer in Routine Clinical Practice: A Global Systematic Review.Semantic proximity Read ↗

Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS).Semantic proximity Read ↗

Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging MarketsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.